… Atypical lobular hyperplasia and lobular carcinoma in situ (LCIS) are defined by the
presence of cells exhibiting characteristic “lobular neoplasia” (LN) cytological features. The LN …

… The results of 766 stereotactic core needle biopsies performed for microcalcifications
between March 4, 1998, and November 9, 2000, were reviewed. Stereotactic biopsies were …

… Comprehensive Cancer Network 2015 Guidelines, we support surgical excision when
atypical lobular hyperplasia and lobular carcinoma in situ are diagnosed on core needle biopsy. …

… [62], where they concluded that personal history of breast cancer is not a predictor of
diagnosis upgrade from atypical hyperplasia (including ADH and atypical lobular hyperplasia). …

… In this literature review, 10 cases of atypical lobular hyperplasia were identified. Of the nine
… excision after a core needle biopsy diagnosis of ADH, atypical lobular hyperplasia, LCIS, high…

… in core needle biopsy specimens raise repeated management questions. These include
atypical ductal hyperplasia, lobular neoplasia (atypical lobular hyperplasia and lobular …

… The significance of LIN diagnosed at core needle biopsy (CNB) is unclear, although many
groups … continue to use the term LCIS to distinguish it from atypical lobular hyperplasia (ALH). …

… were described as ADH, and five, as atypical lobular hyperplasia. Surgical correlation was
available for 22 lesions in 19 patients, (18 ADH and four atypical lobular hyperplasia), which …

… carcinoma in situ (25%, 17 of 67 lesions) versus atypical lobular hyperplasia (22%, 21 of
97 … Of the 278 (0.9%) total lesions with a core needle diagnosis of lobular neoplasia, 100 (36%) …

… PBLs were divided into intraductal papilloma (IDP) and IDP associated with atypical
ductal or lobular hyperplasia (ADH/ALH). Surgical pathology of all lesions was reviewed and …